Business Context and Reporting Period
Company: Tempest Therapeutics, Inc. (TPST)
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2024
Reporting Period: Second Quarter ended June 30, 2024
Business Context: The filing serves as a notification that the Company issued a press release on August 8, 2024, announcing its financial results for the quarter ended June 30, 2024, and providing business updates.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references an attached press release (Exhibit 99.1) for details. Consequently, the following metrics are not available in the source text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not disclose specific material changes in financial performance or operations compared to the prior period. It only confirms the issuance of a press release containing these results.
Guidance, Outlook, and Risks
Management Commentary: The Company announced a business update alongside financial results, but the specific content of this commentary is not included in the 8-K text.
Guidance and Outlook: No forward-looking guidance or outlook figures are present in the provided text.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing excerpt.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release dated August 8, 2024) for actual revenue, net loss, cash position, and burn rate figures.
- Verify the specific business highlights and clinical or operational milestones mentioned in the referenced press release.
- Check for any forward-looking statements or updated guidance regarding future funding needs or product timelines in the full press release.
- Confirm the status of the Series A Junior Participating Preferred Purchase Rights listed in the securities table, as no trading symbol is assigned.